Amicus Inc. / DE

DOVER, DE · Founded 2026 · CIK 0002141196 · Biotech · Acquired

Rare disease therapeutics and medicines for genetically defined conditions

Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50K
1 Form D · Jun 2026
4 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2663UNIVERSAL CELLS, INC.—$60K
2664ISPIN, INC.——
2665Path BioAnalytics, Inc.——
2666Amicus Inc. / DE—$50K
2667Scudo Biosciences Inc—$50K
2668Orna Therapeutics——
2669ePurines, Inc.—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Hortense Gimonet-LeeDirector · Executive Officer
  • Tanvirul HoqueDirector · Executive Officer
  • Abraham LeeDirector · Executive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.